Navigation Links
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
Date:2/22/2012

MALVERN, Pa., and ALLSCHWIL/BASEL, Switzerland, Feb. 23, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Actelion Pharmaceuticals Ltd. (SWX: ATLN.S) announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX® (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease.  Under the terms of the agreement, Actelion will receive exclusive rights to commercialize XIAFLEX for the treatment of Dupuytren's contracture and Peyronie's disease in Canada, Australia, Brazil and Mexico upon receipt of the respective regulatory approvals. Actelion will be primarily responsible for the applicable regulatory and commercialization activities for XIAFLEX in these countries.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

XIAFLEX has been approved by the U.S. Food and Drug Administration and the European Medicines Agency as a treatment for Dupuytren's contracture, and is also in development in Japan. In addition, XIAFLEX has been accepted for review by Health Canada for the treatment of Dupuytren's contracture in Canada and regulatory action is expected in the second half of 2012.  Actelion expects to file for approval of XIAFLEX for the treatment of Dupuytren's contracture in Australia, Brazil and Mexico over the next 12 months.  XIAFLEX is also being evaluated in a global phase III development program for Peyronie's disease with top-line data expected in late second quarter 2012.

"Today, Actelion and Auxilium have forged a partnership, which we believe has the opportunity to offer, subject to regulatory approval, the first, effective nonsurgical treatment for two diseases in multiple new ge
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... WHITE PLAINS, N.Y. , June 19, 2013 /PRNewswire/ ... is supporting more than 300 research projects with one ... patients. And in 2013, "Team In Training" (TNT), a ... largest endurance sports training program, is marking its landmark ... LLS invest more than $875 million in research to ...
(Date:6/19/2013)... June 19, 2013  Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... the number one overall pharmacy equipment vendor in ... KLAS, a leading independent healthcare research firm, compared ... in its annual rankings. Omnicell also received the ...
(Date:6/19/2013)... , 19. Juni 2013 /PRNewswire/ ... dass mit der Entwicklung von SCS ... Schritt in der Beschichtung mit Parylene ... Vorteile von biokompatiblem Parylene mit antimikrobiellen ... Beseitigung schädlicher Mikroorganismen auf beschichteten medizinischen ...
Breaking Medicine Technology:Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... 7 AMN Healthcare Services, Inc. (NYSE: AHS ), ... host its quarterly conference call to discuss third quarter results ... The company also expects to issue an earnings news release ... at approximately 4:00 p.m. Eastern Time. , A live webcast ...
... Dynatronics Corporation (Nasdaq: DYNT ) today announced the appointment ... production and research and development, replacing Ronald Hatch, who has ... management team," said Kelvyn Cullimore Jr., chairman and president of ... our manufacturing operation as well as our research and development ...
Cached Medicine Technology:AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday, October 29, 2009 2Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development 2
(Date:6/19/2013)... According to a June 17, 2013 Allure ... is not uncommon for a person to suffer from a ... is likely to forget to reapply sunscreen properly and end ... and itchy. When this occurs, it is essential to act ... people do not realize that milk contains proteins, fats, and ...
(Date:6/19/2013)... study led by researchers at The University of Texas ... to show remarkable promise for the treatment of relapsed ... recent interim findings of the 18-center Phase 2 study ... of Medicine . Previous interim findings were presented in ... Annual Meeting and Exposition. , Unprecedented results, ...
(Date:6/19/2013)... The results of three important studies have been published ... journal of the Congress of Neurological Surgeons . ... & Wilkins , a part of Wolters Kluwer ... learning" using artificial neural networks (ANNs) may improve the ... cancers. Another study in the June Neurosurgery ...
(Date:6/19/2013)... reveals significant disparities between minority and white clients ... programs. Moreover, these disparities vary widely from state ... for most states there,s something amiss," says Stephan ... "There are strong racial and ethnic disparities for ... treatment programs successfully, and those disparities are something ...
(Date:6/19/2013)... no-strings sexual encounters are increasingly common on college ... others to "hook up"? A new study by ... and Preventive Medicine, published online by the ... certain factors and behaviors associated with sexual hookups, ... the potential for negative emotional and physical health ...
Breaking Medicine News(10 mins):Health News:Skin Care – How to treat Sunburn 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Why are some college students more likely to 'hook up'? 2
... , SUNDAY, Aug. 14 (HealthDay News) -- As ... and kids that children with contagious infections, such as ... the appropriate treatment. According to the experts from ... Del., strep throat is just one of several common ...
... PHILADELPHIA (August 15, 2011)Lymphoma is a cancer that affects ... In a subtype of the disease called extranodal lymphoma, ... and tonsils. Patients with extranodal lymphoma of the head ... frequently damages the salivary glands and causes dry mouth, ...
... Calif. - Like fine chefs, scientists are seemingly approaching a ... type of tissue from human embryonic stem cells. You need ... of growth factors, skill and patience, a laboratory tissue culture ... of newly generated cells lurks a big potential problem: Any ...
... 13 (HealthDay News) -- Heat safety needs to be at ... school sports this month, an expert says. "Players and ... heat stroke," Loyola University Health System athletic trainer Jennifer Janczak ... school football players died of heat stroke, according to the ...
... Randy Dotinga HealthDay Reporter , FRIDAY, Aug. ... who undergo prostate removal often suffer more from incontinence ... about possible aftereffects. The findings suggest there,s a ... post-surgery and what actually happens -- and that many ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, ... chat might seem like innovations best suited to passing ... usefulness in helping people with psychological disorders. The ... people with anxiety and depression, according to recent research. ...
Cached Medicine News:Health News:Kids Urged to Take Steps to Avoid Spreading Illness at School 2Health News:IMRT improves outcomes in patients with extranodal lymphoma of the head and neck 2Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 2Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 3Health News:Stanford discovery may eliminate potentially lethal side effect of stem cell therapy 4Health News:Many Men Underestimate Prostate Surgery Side Effects 2Health News:Many Men Underestimate Prostate Surgery Side Effects 3Health News:From the Couch to the Computer: A New Take on Therapy 2Health News:From the Couch to the Computer: A New Take on Therapy 3
... features of the Mastercycler ep Extremely ... blocks with SteadySlope technology Intuitive graphic ... device, a Mini-Satellite system, or a PC-controlled ... (Electronic Sample Protection) Optional motorized lid for ...
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
... Thermo Electron's most advanced personal gradient option ... use sophisticated onboard software and a large ... offer performance, accuracy and simplicity in thermal ... customer driven features built up on years ...
Medicine Products: